Related references
Note: Only part of the references are listed.Dimethylarginine dimethylaminohydrolase overexpression enhances insulin sensitivity
Karsten Sydow et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Plasma concentration of asymmetric climethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy
Maria Lajer et al.
DIABETES CARE (2008)
Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan
Enyu Imai et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes
Katarzyna Krzyzanowska et al.
DIABETES CARE (2007)
Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease
Yuriko Matsumoto et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy
Takahiko Nakagawa et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Improving proteinuria, endothelial functions and asymmetric dimethylarginine levels in chronic kidney disease: Ramipril versus valsartan
Mahmut Ilker Yilmaz et al.
BLOOD PURIFICATION (2007)
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2006)
ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease
K. Caglar et al.
KIDNEY INTERNATIONAL (2006)
Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension
F Perticone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Asymmetric dimethylarginine: A cardiovascular risk factor and a uremic toxin coming of age?
JT Kielstein et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Asymmetric dimethylarginine and progression of chronic kidney disease:: The mild to moderate kidney disease study
D Fliser et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Performance of the modification of diet in renal disease and Cockcroft-Gault equations health and in chronic kidney in the estimation of GFR in disease
ED Poggio et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Renal nitric oxide production is decreased in diabetic rats and improved by AT1 receptor blockade
AS Awad et al.
JOURNAL OF HYPERTENSION (2004)
Role of nitric oxide in diabetic nephropathy
SS Prabhakar
SEMINARS IN NEPHROLOGY (2004)
A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease
J Lin et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase
V Achan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus
A Ito et al.
CIRCULATION JOURNAL (2002)
Impaired nitric oxide synthase pathway in diabetes mellitus - Role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase
KY Lin et al.
CIRCULATION (2002)
Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical NG, NG-dimethylarginine in human essential hypertension
C Delles et al.
AMERICAN JOURNAL OF HYPERTENSION (2002)
Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine
VP Valkonen et al.
LANCET (2001)
Endothelial cell dysfunction leading to diabetic nephropathy - Focus on nitric oxide
MS Goligorsky et al.
HYPERTENSION (2001)
Share Paper
